January 2017

Newsletter-Banner

AFA’s Public Policy VP Details Experience at CTAD Conference

Eric Sokol, vice president of public policy at the Alzheimer’s Foundation of America (AFA), attended the Clinical Trials in Alzheimer’s Disease (CTAD) conference in December. He gave an overview of his experiences at the conference, which included learning more about the role of caregivers in drug therapy development. To read a full account of Sokol’s impression of the conference, go here.

Potential Target for Anti-Alzheimer’s Treatments May Be Identified

Researchers at the University of Luxembourg say they have identified a gene that could lead to the potential development of Alzheimer’s disease treatments. The ubiquitin-specific peptidase (USP9) gene has an indirect impact on the tau protein, which is thought to play a role in Alzheimer’s disease. The research team found that USP9 “knockdown” reduced the activity of tau genes. The researchers’ findings were published in Molecular Biology and can be found here.

Living in Areas with Heavy Traffic May Increase Risk of Dementia, Researchers Say

Researchers at Public Health Ontario (PHO) and the Institute for Clinical Evaluative Sciences (ICES) say living close to areas with high traffic raises the risk of developing dementia. “We know from previous research that air pollutants can get into the blood stream and lead to inflammation, which is linked with cardiovascular disease and possibly other conditions such as diabetes. This study suggests air pollutants that can get into the brain via the blood stream can lead to neurological problems,” says Dr. Ray Copes, chief of environmental and occupational health at PHO. To read the full paper, go here.

PBS Scheduled to Air Documentary on Alzheimer’s in America 

A documentary on Alzheimer’s disease, titled “Alzheimer’s: Every Minute Counts,” will premiere January 25 at 10 p.m. ET on PBS. The documentary will highlight the effects of Alzheimer’s in America and the consequences the country faces without a medical breakthrough for the disease. For more information, go here.

The 13th International Conference on Alzheimer’s and Parkinson’s Disease Registration Deadline, March 14

Save the date! AD/PD™ 2017 takes place March 29 to April 2, 2017, in Vienna, Austria. The conference brings together clinical investigators, basic scientists, established investigators, and young talents. To learn more about the conference, go here.

Save the Date for the Cognitive Aging Summit III, April 6-7

Covened by the National Institute on Aging, the Cognitive Aging Summit III “will bring together experts in a variety of research fields to discuss the most cutting-edge advances in our understanding of age-related related brain and cognitive changes, with a particular focus on resilience and reserve.” For more information, please go here.